Equities

Sharps Technology Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
STSS:NAQ

Sharps Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.78
  • Today's Change0.05 / 2.89%
  • Shares traded213.39k
  • 1 Year change-97.92%
  • Beta2.2046
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

  • Revenue in USD (TTM)2.51m
  • Net income in USD-104.37m
  • Incorporated2022
  • Employees5.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
EUDA Health Holdings Ltd5.16m-2.06m36.85m117.0063.09----7.140.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
TELA Bio Inc77.06m-39.00m38.00m209.00--22.49--0.4932-0.8863-0.88631.750.03861.342.016.85368,684.20-68.06-51.29-96.57-60.7067.2366.26-50.61-88.022.62-7.250.9638--18.5635.0218.91---18.18--
Vivos Inc48.63k-3.01m38.60m10.00--17.71--793.77-0.0068-0.00680.00010.00480.0275--10.03---170.12-166.49-178.25-242.01-127.332.81-6,191.01-11,105.9819.81--0.00--43.5924.13-0.5424------
Icecure Medical Ltd2.98m-15.29m39.85m64.00--4.28--13.39-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Precipio Inc22.80m-1.25m42.19m54.00--3.06174.331.85-0.835-0.83514.637.881.2018.2615.31422,222.20-6.58-38.01-8.60-46.9844.8233.80-5.50-71.341.10-24.190.074--21.9542.7426.70--32.31--
Spectral AI Inc23.17m-16.37m42.96m78.00------1.85-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
CS Diagnostics Corp0.00-341.62k46.25m5.00---------531,454.00-531,454.00----0.00-------579.61-1,264.84-----------209,220.50------------32.83------
Cytosorbents Corp34.35m-10.59m47.26m149.00--5.24--1.38-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
Sharps Technology Inc2.51m-104.37m50.16m5.00--0.1103--19.97-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Heartbeam Inc0.00-20.62m52.01m16.00--127.72-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
Alpha Pro Tech Ltd59.10m3.68m53.98m130.0015.260.856811.980.91340.34150.34155.466.080.8031.6410.62454,584.605.0013.855.2314.5838.2140.646.2312.787.70--0.000.00-5.544.39-6.215.5424.04--
Nutriband Inc2.28m-34.59m54.06m13.00--7.15--23.73-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Medinotec Inc11.43m2.34m58.78m51.0025.0810.6924.695.140.19940.19940.97340.46791.874.047.03224,166.5038.33--49.87--58.25--20.48--3.8937.940.00008--81.53--633.61------
electroCore, Inc.29.84m-14.16m60.61m73.00------2.03-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Outset Medical Inc119.48m-81.65m63.91m310.00--0.4995--0.5349-6.78-6.787.876.990.44231.363.74385,406.40-30.23-37.90-35.71-43.8239.1324.03-68.34-116.475.40-10.190.4312--5.0919.0636.20---38.55--
Neuraxis Inc3.36m-8.37m63.92m21.00--26.00--19.01-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
Data as of Mar 02 2026. Currency figures normalised to Sharps Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

29.42%Per cent of shares held by top holders
HolderShares% Held
Schonfeld Strategic Advisors LLCas of 31 Dec 20251.54m5.99%
Saba Capital Management LPas of 16 Jan 20261.51m5.89%
Pantera Advisors LLCas of 31 Dec 20251.15m4.48%
Scoggin Management LPas of 31 Dec 20251.15m4.48%
HBK Investments LPas of 31 Dec 2025769.23k3.00%
Feynman Point Asset Managementas of 31 Dec 2025552.14k2.15%
The Vanguard Group, Inc.as of 31 Dec 2025341.38k1.33%
Geode Capital Management LLCas of 31 Dec 2025280.37k1.09%
Vanguard Fiduciary Trust Co.as of 31 Dec 2025164.48k0.64%
BlackRock Fund Advisorsas of 31 Dec 202594.54k0.37%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.